Pages that link to "Q71729147"
Jump to navigation
Jump to search
The following pages link to Lectin-bearing polymerized liposomes as potential oral vaccine carriers (Q71729147):
Displaying 46 items.
- Small-scale systems for in vivo drug delivery (Q28206028) (← links)
- Cancer nanotechnology: opportunities and challenges (Q29615481) (← links)
- Recent advances with liposomes as pharmaceutical carriers (Q29616702) (← links)
- Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries. (Q31155344) (← links)
- Fucosyled neoglycolipids: synthesis and interaction with a phospholipid. (Q31860538) (← links)
- Selected advances in drug delivery and tissue engineering (Q33750622) (← links)
- Advances in vaccine adjuvants (Q33764666) (← links)
- Quantitative analysis of phospholipids using nanostructured laser desorption ionization targets (Q33822500) (← links)
- New advances in microsphere-based single-dose vaccines (Q33933148) (← links)
- Human intestinal M cells display the sialyl Lewis A antigen. (Q34000445) (← links)
- Lectin-mediated mucosal delivery of drugs and microparticles (Q34019886) (← links)
- Recent developments in adjuvants for vaccines against infectious diseases (Q34376294) (← links)
- Oral vaccination in man using antigens in particles: current status (Q34384614) (← links)
- Microparticle vaccine approaches to stimulate mucosal immunisation. (Q34387802) (← links)
- Recent advances in vaccine adjuvants (Q34756188) (← links)
- Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano‐bilosomes (Q35287340) (← links)
- Mucosal immunity: overcoming the barrier for induction of proximal responses. (Q35838661) (← links)
- Rh-I-UEA-1 Polymerized Liposomes Target and Image Adenomatous Polyps in the APCMin/ Mouse Using Optical Colonography (Q36153703) (← links)
- M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens. (Q37256573) (← links)
- Mucosal Vaccine Development Based on Liposome Technology (Q37581129) (← links)
- Nanomaterials for Cancer Therapy and Imaging (Q37601740) (← links)
- Gut-associated lymphoid tissues for the development of oral vaccines (Q37914349) (← links)
- Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization (Q38330161) (← links)
- Development of the Novel PEG-PE-Based Polymer for the Reversible Attachment of Specific Ligands to Liposomes: Synthesis and in Vitro Characterization (Q38769940) (← links)
- Current state and challenges in developing oral vaccines (Q39259629) (← links)
- Oral microparticulate vaccine for melanoma using M-cell targeting (Q39461635) (← links)
- The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual (Q41429082) (← links)
- Diacetylenic lipids in the design of stable lipopolymers able to complex and protect plasmid DNA. (Q41919248) (← links)
- Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres (Q43543136) (← links)
- p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups (Q43564829) (← links)
- Intestinal patches for oral drug delivery (Q43618337) (← links)
- Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form (Q43665618) (← links)
- Targeting polymerised liposome vaccine carriers to intestinal M cells (Q43745138) (← links)
- Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization (Q44053148) (← links)
- Characterization of diacetylenic liposomes as carriers for oral vaccines (Q44323018) (← links)
- Specific interaction of lectins with liposomes and monolayers bearing neoglycolipids. (Q44595006) (← links)
- Innovations in oral gene delivery: challenges and potentials. (Q45874123) (← links)
- Immunization without needles (Q46308392) (← links)
- Chemical Modification of Chitosan for Efficient Vaccine Delivery. (Q49693828) (← links)
- Biomimetic design in microparticulate vaccines (Q51835912) (← links)
- Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses (Q74100933) (← links)
- Peyer's patch dendritic cells and the induction of mucosal immune responses (Q74552624) (← links)
- Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope (Q81747172) (← links)
- Effects of tremella–alginate–liposome encapsulation on oral delivery of inactivated H5N3 vaccine (Q85193165) (← links)
- Adapting liposomes for oral drug delivery (Q91603851) (← links)
- Formulation technologies for oral vaccines (Q91986433) (← links)